QUiCKR Bio
Biotechnology · Cell & Gene Therapy
Funding and backers
Backers
2
StartX, HCVC
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 2024
Website went live first capture in the Wayback Machine
Backed byfrom the funds' portfolios and accelerator catalogs
HCVC Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to…
Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent…
Amplo is developing gene therapies (AAV) for diseases affecting the neuromuscular junction (e.g. congenital myasthenia, ALS, ageing…
Carmine Therapeutics is pioneering a powerful new class of genetic medicines based on red blood cell extracellular vesicles (RBCEVs).
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely